Dyadic International DYAI
NASDAQ DYAI
$0.38 +0.04 (+11.76%)
At close: Nov 9, 2026 · 4:00 PM EST

Dyadic International (DYAI) Return on Equity [ROE] (2018 - 2026)

Updated

Dyadic International (DYAI) recorded Return on Equity [ROE] of -1768.38% in Q1 2026, down 1424.90 percentage points from -343.49% a year earlier and down 1384.78 percentage points from the prior quarter.

Analysis

Dyadic International (DYAI) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Dyadic International reported Return on Equity [ROE] of -397.80%, down 257.14 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for seven straight years, with a five-year change of -368.80 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -140.66% in FY2024 (-48.56 pp), -92.10% in FY2023 (-23.13 pp), -68.97% in FY2022 (-13.16 pp) and -55.81% in FY2021 (-26.81 pp).
  • Quarterly Return on Equity [ROE] has ranged from -16539.97% in Q4 2021 to -81.36% in Q1 2022 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined for 11 consecutive quarters, with an average year-over-year change of -655.50 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 16454.19 percentage points in Q4 2022, against a drop of 16508.06 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -383.60% (Q4 2025), -707.53% (Q3 2025) and -2831.79% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 19.33%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.63%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 21.60%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 72.13%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -31.17%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 4.66%
10 Dyadic International 13.85 Mn 7.25 Mn - -1,768.38%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,768.38%
Dec 31, 2025 -383.60%
Sep 30, 2025 -707.53%
Jun 30, 2025 -2,831.79%
Mar 31, 2025 -343.49%
Dec 31, 2024 -199.64%
Sep 30, 2024 -194.25%
Jun 30, 2024 -203.07%
Mar 31, 2024 -152.73%
Dec 31, 2023 -115.48%
Sep 30, 2023 -95.93%
Jun 30, 2023 -83.18%
Mar 31, 2023 -85.57%
Dec 31, 2022 -85.79%
Sep 30, 2022 -92.78%
Jun 30, 2022 -90.81%
Mar 31, 2022 -81.36%
Dec 31, 2021 -16,539.97%
Sep 30, 2021 -14,779.64%
Jun 30, 2021 -13,630.02%
API Access

Dyadic International Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DYAI&period=max&api_key=YOUR_API_KEY